Ag. Thrift et al., Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study, BR MED J, 318(7186), 1999, pp. 759-764
Citations number
31
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objective To examine the association between use of aspirin or other non-st
eroidal anti-inflammatory drugs and intracerebral haemorrhage.
Design Case-control study.
Setting 13 major city hospitals in the Melbourne and metropolitan area.
Subjects 331 consecutive cases of stroke verified by computed tomography or
postmortem examination, and 331 age (+/- 5 years) and sex matched controls
who were community based neighbours.
Interventions (Questionnaire administered to all subjects either directly o
r by proxy with the next of kin. Drug use was validated by reviewing prescr
ibing records held by the participants' doctors.
Main outcome measures Previous use of aspirin or other non-steroidal anti-i
nflammatory drugs.
Results Univariate analysis showed no increased risk of intracerebral haemo
rrhage with low dose aspirin use in the preceding 2 weeks. Using multiple l
ogistic regression to control for possible confounding factors, the odds ra
tio associated with die use of aspirin was 1.00 (95% confidence interval 0.
60 to 1.66, P = 0.998) and the odds ratio associated with the use of other
non-steroidal anti-inflammatory drugs was 0.85 (0.45 to 1.61, P = 0.611) co
mpared with respective non-users in the preceding fortnight. Moderate to hi
gh doses of aspirin (> 1225 mg/week spread over at least three doses) yield
ed an odds ratio of 3.05 (1.02 to 9.14, P= 0.047). There was no evidence of
an increased risk among subgroups defined by age, sex, Mood pressure statu
s, alcohol intake, smoking, and the presence or absence of previous cardiov
ascular disease.
Conclusions No increase in risk of intracerebral haemorrhage was found amon
g aspirin users overall or among those who took low doses of the drug or ot
her non-steroidal anti-inflammatory drugs. These data provide evidence that
doses of aspirin usually used for prophylaxis against vascular disease pro
duce no substantial increase in risk of intracerebral haemorrhage.